COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,684 Articles (22,913 medRxiv, 8,771 bioRxiv)

Most recent first Previous |  Page 1704: Articles 17031-17040  | Next

Symptoms and risk factors for hospitalization of COVID-19 presented in primary care
Rabady, S., Kamenski, G., Brose, M., Lammel, O., Poggenburg, S., Redlberger-Fritz, M., Stiasny, K., Wendler, M., Weseslindtner, L., Zehetmayer, S., Hoffmann, K.
10.1101/2021.03.26.21254331 — Posted: 2021-03-29
SARS-CoV-2, a threat to marine mammals? A study from Italian seawaters
Audino, T., Grattarola, C., Centelleghe, C., Peletto, S., Giorda, F., Florio, C. L., Caramelli, M., Bozzetta, M. E., Mazzariol, S., Di Guardo, G., Lauriano, G., Casalone, C.
10.1101/2021.03.29.437540 — Posted: 2021-03-29
Using Google Health Trends to investigate COVID19 incidence in Africa
Fulk, A., Romero-Alvarez, D., Saymeh, Q. A., Saint Onge, J., Peterson, A. T., Agusto, F. B.
10.1101/2021.03.26.21254369 — Posted: 2021-03-29
Enrichment of SARS-CoV-2 entry factors and interacting intracellular genes in peripheral immune cells
Devaprasad, A., Pandit, A.
10.1101/2021.03.29.437515 — Posted: 2021-03-29
COVID-19 dominant D614G mutation in the SARS-CoV-2 spike protein desensitizes its temperature-dependent denaturation
Yang, T.-J., Yu, P.-Y., Chang, Y.-C., Kuo, C.-W., Khoo, K.-H., Hsu, S.-T. D.
10.1101/2021.03.28.437426 — Posted: 2021-03-29
SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates
Milman, O., Yelin, I., Aharony, N., Katz, R., Herzel, E., Ben-Tov, A., Kuint, J., Gazit, S., Chodick, G., Patalon, T., Kishony, R.
10.1101/2021.03.26.21254394 — Posted: 2021-03-29 Discussion: Onsite
Attitudes toward COVID-19 illness and COVID-19 vaccination among pregnant women: a cross-sectional multicenter study during August-December 2020
Battarbee, A., Stockwell, M., Varner, M., Newes-Adey, G., Daugherty, M., Gyamfi-Bannerman, C., Tita, A., Vorwaller, K., Vargas, C., Subramaniam, A., Reichle, L., Galang, R., Powers, E., Lucca-Susana, M., Parks, M., Chen, T. J., Razzaghi, H., Dawood, F. S.
10.1101/2021.03.26.21254402 — Posted: 2021-03-29
A lipid nanoparticle RBD-hFc mRNA vaccine protects hACE2 transgenic mice against lethal SARS-CoV-2 infection
Elia, U., Rotem, S., Bar-Haim, E., Ramishetti, S., Naidu, G. S., Gur, D., Aftalion, M., Israeli, M., Bercovich-Kinori, A., Alcalay, R., Makdasi, E., Chitlaru, T., Rosenfeld, R., Israely, T., Melamed, S., Abutbul Ionita, I., Danino, D., Peer, D., Cohen, O.
10.1101/2021.03.29.436639 — Posted: 2021-03-29
Modeling Substrate Coordination to Zn-Bound Angiotensin Converting Enzyme 2
Fatouros, P. R., Roy, U., Sur, S.
10.1101/2021.03.27.437352 — Posted: 2021-03-29
Preliminary report on SARS-CoV-2 Spike mutation T478K
Di Giacomo, S., Mercatelli, D., Rakhimov, A., Giorgi, F. M.
10.1101/2021.03.28.437369 — Posted: 2021-03-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).